These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 29934070)

  • 1. Norepinephrine augmented in vitro growth of uropathogenic E. coli in Type 2 diabetes mellitus and its suppression by silodosin (alpha blocker).
    Gond DP; Singh S; Agrawal NK
    Diagn Microbiol Infect Dis; 2018 Oct; 92(2):85-89. PubMed ID: 29934070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral supplementation of trans-cinnamaldehyde reduces uropathogenic Escherichia coli colonization in a mouse model.
    Narayanan A; Muyyarikkandy MS; Mooyottu S; Venkitanarayanan K; Amalaradjou MA
    Lett Appl Microbiol; 2017 Mar; 64(3):192-197. PubMed ID: 28063174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of virulence factors and phylogenetic characterization of uropathogenic Escherichia coli causing urinary tract infection in patients with and without diabetes mellitus.
    Harwalkar A; Gupta S; Rao A; Srinivasa H
    Trans R Soc Trop Med Hyg; 2015 Dec; 109(12):769-74. PubMed ID: 26567223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic cranberry juice combinations with natural-borne antimicrobials for the eradication of uropathogenic Escherichia coli biofilm within a short time.
    Kim HW; Chung DH; Kim SA; Rhee MS
    Lett Appl Microbiol; 2019 Apr; 68(4):321-328. PubMed ID: 30801748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasion and translocation of uropathogenic Escherichia coli isolated from urosepsis and patients with community-acquired urinary tract infection.
    Owrangi B; Masters N; Kuballa A; O'Dea C; Vollmerhausen TL; Katouli M
    Eur J Clin Microbiol Infect Dis; 2018 May; 37(5):833-839. PubMed ID: 29340897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of uropathogenic Escherichia Coli in the bladders of female patients with sterile urine after antibiotic therapies.
    Liu SC; Han XM; Shi M; Pang ZL
    J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):710-715. PubMed ID: 27752899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea.
    Lee JH; Subhadra B; Son YJ; Kim DH; Park HS; Kim JM; Koo SH; Oh MH; Kim HJ; Choi CH
    Lett Appl Microbiol; 2016 Jan; 62(1):84-90. PubMed ID: 26518617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Payload hardware and experimental protocol development to enable future testing of the effect of space microgravity on the resistance to gentamicin of uropathogenic Escherichia coli and its σ
    Matin AC; Wang JH; Keyhan M; Singh R; Benoit M; Parra MP; Padgen MR; Ricco AJ; Chin M; Friedericks CR; Chinn TN; Cohen A; Henschke MB; Snyder TV; Lera MP; Ross SS; Mayberry CM; Choi S; Wu DT; Tan MX; Boone TD; Beasley CC; Piccini ME; Spremo SM
    Life Sci Space Res (Amst); 2017 Nov; 15():1-10. PubMed ID: 29198308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the presence of vesicoureteral reflux affect in vitro uropathogenic E. coli growth rate in urine?
    Soylu A; Karaman M; Alaygut D; Çamlar SA; Türkmen M; Kavukçu S
    Int Urol Nephrol; 2016 Feb; 48(2):151-4. PubMed ID: 26681193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteolin decreases the attachment, invasion and cytotoxicity of UPEC in bladder epithelial cells and inhibits UPEC biofilm formation.
    Shen XF; Ren LB; Teng Y; Zheng S; Yang XL; Guo XJ; Wang XY; Sha KH; Li N; Xu GY; Tian HW; Wang XY; Liu XK; Li J; Huang N
    Food Chem Toxicol; 2014 Oct; 72():204-11. PubMed ID: 25051393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children.
    Yun KW; Kim HY; Park HK; Kim W; Lim IS
    J Microbiol Immunol Infect; 2014 Dec; 47(6):455-61. PubMed ID: 24064288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uropathogenic Escherichia coli mediated urinary tract infection.
    Totsika M; Moriel DG; Idris A; Rogers BA; Wurpel DJ; Phan MD; Paterson DL; Schembri MA
    Curr Drug Targets; 2012 Oct; 13(11):1386-99. PubMed ID: 22664092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition and Inactivation of Uropathogenic
    Narayanan A; Nair MS; Muyyarikkandy MS; Amalaradjou MA
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29880781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Consumption of Cranberry Exerts ex Vivo Antiadhesive Activity against FimH-Dominated Uropathogenic Escherichia coli: A Combined in Vivo, ex Vivo, and in Vitro Study of an Extract from Vaccinium macrocarpon.
    Rafsanjany N; Senker J; Brandt S; Dobrindt U; Hensel A
    J Agric Food Chem; 2015 Oct; 63(40):8804-18. PubMed ID: 26330108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper primes adaptation of uropathogenic Escherichia coli to superoxide stress by activating superoxide dismutases.
    Saenkham P; Ritter M; Donati GL; Subashchandrabose S
    PLoS Pathog; 2020 Aug; 16(8):e1008856. PubMed ID: 32845936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DFI-seq identification of environment-specific gene expression in uropathogenic Escherichia coli.
    Madelung M; Kronborg T; Doktor TK; Struve C; Krogfelt KA; Møller-Jensen J
    BMC Microbiol; 2017 Apr; 17(1):99. PubMed ID: 28438119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluation.
    Klein T; Abgottspon D; Wittwer M; Rabbani S; Herold J; Jiang X; Kleeb S; Lüthi C; Scharenberg M; Bezençon J; Gubler E; Pang L; Smiesko M; Cutting B; Schwardt O; Ernst B
    J Med Chem; 2010 Dec; 53(24):8627-41. PubMed ID: 21105658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of Multidrug Resistant Uropathogenic Escherichia coli in Iran: a Systematic Review and Meta-Analysis.
    Hadifar S; Moghoofei M; Nematollahi S; Ramazanzadeh R; Sedighi M; Salehi-Abargouei A; Miri A
    Jpn J Infect Dis; 2017 Jan; 70(1):19-25. PubMed ID: 27000462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of prevalence, immunogenicity and efficacy of FyuA iron receptor in uropathogenic Escherichia coli isolates as a vaccine target against urinary tract infection.
    Habibi M; Asadi Karam MR; Bouzari S
    Microb Pathog; 2017 Sep; 110():477-483. PubMed ID: 28754265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiadhesive hydroalcoholic extract from Apium graveolens fruits prevents bladder and kidney infection against uropathogenic E. coli.
    Sarshar S; Sendker J; Qin X; Goycoolea FM; Asadi Karam MR; Habibi M; Bouzari S; Dobrindt U; Hensel A
    Fitoterapia; 2018 Jun; 127():237-244. PubMed ID: 29496563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.